Abstract
USFDA, and ICH and other regulatory bodies areplacing a strong emphasis on the detection of contaminants in pharmaceutical active ingredients (APIs) and purity standards that must be met. The process of acquiring and reviewing data to establish the biological safety of each impurity and, thus, its level of qualification the necessity and extent of medication impurity profiling in pharmaceutical research. To identify pollutants, a variety of chromatographic and spectroscopic methods can be applied either alone or in combination with other methods. Impurities can be found and characterized using a variety of techniques like TLC, HPLC, HPTLC, AAS, etc. The discipline of Profiling impurities has utilized conventional LC and HPLC. This method numerous uses might result from its sensitivity, affordability, ability to disentangle a variety of detectors and stationary phases. The most popular separating method is TLC among the several Planar Chromatographic Methods, for isolation of contaminants; as a result of its affordability and ease of use in comparison to HPLC. A popular method for isolating impurities is thin-layer chromatography (HPTLC), which has advanced throughout time. Headspace gas phase separation is a highly favored method for determining the presence of leftover solvents. Hyphenated approaches have revolutionized impurity profiling by enabling structural identification of impurities in addition to their separation.
Keywords
impurities, Analytical method development, Spectrophotometry, Chromatography
Introduction
Since it provides precise high-quality active compounds in pharmaceuticals (APIs), the majority drug industry acts as the basis for all other pharmaceuticals enterprises. The standard of pharmaceuticals that are introduced to the market has drawn a lot of interest during past few decades. Manufacturing superior products is the Producing high-quality good’s is the main issue confronting the pharmaceutical and bulk drug industries. Vigorous quality control inspections are required to preserve the caliber and integrity of any industry's output. Raw materials used, manufacturing process, the type of crystallization, and the purifying procedure are some of the cans have an impact on a pharmaceutical ingredient’s purity. The concept of pure is dynamic and inextricably linked to advancements in analytical chemistry. The pharmacopoeias set very strict limitations on the amounts of different contaminants in addition to requiring purity. It is evident that modern separation techniques are important to scientific study today since they allow for the simultaneous separation and quantification of the components, which facilitates the identification and isolation of contaminants. [1,2,3] The contaminants found in APIs are attracting more and more attention. As a result of several regulatory requirements, purity and impurity profiles have recently become crucial. Within Any organic material is considered an impurity in the field of pharmaceuticals that is not part of the drug substance or components, or as undesired compounds that are left behind with APIs. Contamination could appear in medications either in the process of formulating or as the prepared APIs and APIs themselves age. [4] Guidelines for techniques for evaluating contaminants in novel Microbiological pollutants, residual solvents, pharmacological substances, and goods have also ICH authorized the publication. [5]
Reference
- K. M. Alsante,P. Boutre, M. A. Couturier, Pharmaceutical Impurity Identification a Case Study Using a Multidisciplinary Approach, Journal of Pharmaceutical Sciences,2004:93(9):225-229.
- N. R. Rao, S. S. Manikiran, N. L. Prasanthi, Pharmaceutical Impurities, Indian Journal of Pharmaceutical Education and Research,2010:44(3):301-310.
- S. B. Bari, B. R. Kadam,Y. S. Jaiswal,A. A. Shirkhedkar, Impurity Profile and Significance in Active Pharmaceutical Ingredients, Eurasian Journal of Analytical Chemistry,2007:2(1):32-53.
- Federal Register, International Conferences on Harmonization, Data, v4,2006.
- Federal Register, International Conferences on Harmonization, Impurities in New Medicinal Products, Data, v4, 2006
- V. S. Tegeli, G. K. Gajeli, G. K. Chougule, Significance of Impurity Profiling, International Journal of Drug Formulation and Research,2011: 2(4):174-195.
- S. J. Ingale, C. M. Sahu, R. T. Paliwal, Advance Approaches for the Impurity Profiling of Pharmaceutical Drugs, International Journal of Pharmaceutical and Life Sciences,2011:2(7):955-962.
- J. S. Peter, A. Ahmed,W. Yan, An HPLC Chromatographic Reactor Approach for Investigating the Hydrolytic Stability of a Pharmaceutical Compound, Journal of Pharmaceutical and Biomedical Analysis,2006:41(3):883-884.
- T. Radhakrishna, J. Satyanarayana, A. Satyanarayana, Determination of Loratadine and its Related Impurities by HPLC, Journal of Indian Drugs,2002: 39(6):342-343.
- T. Radhakrishna, J. Satyanarayana, A. Sataynarayana, HPLC Method for the Degradation of Celecoxib andIts Related Impurities, Journal of Indian Drugs,2002:40(3):166-168.
- N.H. Zawilla, B. Li, J. Hoogmartens, E. Adams, Improved RP-LC Method Combined with Pulsed Electrochemical Detection for the Analysis of Amikacin, Journal of Pharmaceutical and Biomedical Analysis,2007:43(8):168-173.
- R. Cornelis, Critical Evaluation of Scientific Literature on Trace Elements in Food and Diet, Journal of Pure and Applied Chemistry,2005:77(4):435-459.
- N. Grekas, Organic Impurities in Chemical Drug Substances, Journal of Pharmaceutical Technology Europe,2005:17(10): 24-32.
- A. Choudhary, P. Kaushik, HPTLC a Versatile Tool for the Analysis of Herbal Drugs, Asian Journal of Pharmaceutical Sciences,2020:15(4):1-10.
- V. Patel, M. Patel, Recent Advances in HPTLC, International Journal of Pharmaceutical Sciences and Research,2013: 4(12):537-543.
- M. Soni, R. Tiwari, HPTLC a Tool for Quality Control of Herbal Drugs, Journal of Pharmaceutical and Biomedical Analysis,2011:55(5):988-996.
- M. Bhalekar, P. Waghmare, HPTLC a Promising Analytical Technique for the Estimation of Impurities in Pharmaceuticals, International Journal of Research in Pharmaceutical Sciences,2013:4(1):120-124.
- P. J. Derrick, P. Ratz, The Application of Fourier Transform Infrared Spectroscopy to the Analysis of Pharmaceutical Materials, Journal of Applied Pharmaceutical Science, 2000: 3(4):130-137.
- A. M. Murray, D. J. Kiemle, Application of FTIR Spectroscopy for the Determination of the Quality of Pharmaceuticals, International Journal of Scientific Development and Research,2005:8(1):54-60.
- H. M. Hwang, S. W. Lee, Application of FTIR Spectroscopy for the Detection of Environmental Pollutants, Journal of Environmental Science and Technology,2010:44(1):170-176.
- M. Alam,M. Ali,A Comprehensive Review on High-Performance Thin Layer Chromatography (HPTLC) Method for Quality Control of Herbal Medicines, Journal of Pharmaceutical Sciences and Research,2020:12(3):411-421.
- M. Nisha, M. Ismail, R. Ismail, F. Duncan, L. Maili, Impurity Profiling in Bulk Pharmaceutical Batches Using 19F NMR Spectroscopy and Distinction between Monomeric and Dimeric Impurities by NMR-Based Diffusion Measurements, Journal of Pharmaceutical and Biomedical Analysis,1999:13(4):511-512.
- Shrinivas R. Mane, Sanjay K. Bais, Swapnil Waghmare, Synthesis of Schiff Base from O- Vanillin and Phenyl Urea by Using Catalyst Chloroacetic Acid, International Journal of Pharmacy and Herbal Technology,2024:2(03): 2231-2235.
- M. G. Quaglia, E. Donati, E. Bossu,N. Desideri, F. Campana, Determination of Fenticonazole and its Impurities by Capillary Electrophoresis and High-Performance Liquid Chromatography, Journal of Separation Science,2001:24(5):392-396.
- Shrinivas R. Mane, Sanjay K. Bais, Aditya A. Mali, Microwave Assisted Synthesis of Benzoic Acid, International Journal of Pharmacy and Herbal Technology,2024:2(3):1817-1818.
- Shrinivas R. Mane, Sanjay K. Bais, Sarfaraz Kazi, Gauri Anuse, Microwave Assisted Synthesis of Benzocaine, International Journal of Pharmacy and Herbal Technology,2024:2(3):2076- 2082
Prathamesh Bhagyavant
Corresponding author
Rashtriya College of Pharmacy. Hatnoor Tq. kannad Dist. Chh. Sambhajinagar- 431103
Swapnil Ade
Co-author
Rashtriya College of Pharmacy. Hatnoor Tq. kannad Dist. Chh. Sambhajinagar- 431103
Sayyad J. H.
Co-author
Rashtriya College of Pharmacy. Hatnoor Tq. kannad Dist. Chh. Sambhajinagar- 431103
Sayyad J. H., Prathamesh Bhagyavant*, Swapnil Ade, Impurity Profiling and its Significance Active Pharmaceutical Ingredients, Int. J. Sci. R. Tech., 2025, 2 (12), 211-223. https://doi.org/10.5281/zenodo.17929010
10.5281/zenodo.17929010
